Q517--Pharmacy Compounding Contingency Solicitation for the Boise VA.
ID: 36C26025Q0047Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF260-NETWORK CONTRACT OFFICE 20 (36C260)VANCOUVER, WA, 98662, USA

NAICS

Pharmacies and Drug Retailers (456110)

PSC

MEDICAL- PHARMACOLOGY (Q517)

Original Source

https://sam.gov/opp/996cc1aba1684546b1c5e6b68a87d9a8/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for a Pharmacy Compounding Contingency to support the Boise Veterans Health Care System, as outlined in Solicitation Number 36C26025Q0047. The procurement involves providing hazardous pharmaceutical compounding services, specifically for chemotherapy agents, in compliance with federal and state regulations, including USP <797> standards. This contract, structured as a five-year Indefinite Delivery Indefinite Quantity (IDIQ) agreement, has a minimum guarantee of $500 and a maximum value of $800,000, emphasizing the importance of timely and quality medical services for veterans. Interested parties must submit their proposals by November 20, 2024, at 1:00 PM Pacific Time, and can direct inquiries to Jose E Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.

    Point(s) of Contact
    Jose E Ronstadtjose.ronstadt@va.gov
    (360) 852-9885
    jose.ronstadt@va.gov
    Files
    Title
    Posted
    36C26025Q0047_1.docx
    The Combined Synopsis/Solicitation Notice addresses a Pharmacy Compounding Contingency for the Boise VA. It is issued under Solicitation Number 36C26025Q0047, with a response deadline set for November 20, 2024, at 1:00 PM Pacific Time. The contracting office is located in Vancouver, WA, and further details on the requirements can be found in the specified solicitation documents, which include related attachment on chemotherapy agents. This solicitation is not funded by the Recovery Act and is classified under Product Service Code Q517 and NAICS Code 456110. Interested parties are encouraged to refer to the attached documents for a full understanding of the project scope and specifications. The notice also includes contact information for inquiries.
    Chemotherapy Agent list.xlsx
    The document provides a comprehensive listing of various antineoplastic drugs intended for oncology treatments, detailing their brand names, generic names, National Drug Codes (NDC), and Healthcare Common Procedure Coding System (HCPCS) codes. Each entry includes information on drug categories, routes of administration, prices per unit for multiple ordering periods, and additional relevant specifications. The purpose of this document relates to government Requests for Proposals (RFPs) and federal grants, outlining the available chemotherapy drugs for procurement or grant allocation. The structure includes organized sections for each drug, reflecting the importance of cataloging these medications to ensure efficient distribution and accessibility in healthcare settings. This summary serves as a resource for stakeholders involved in healthcare procurement, facilitating access to critical oncology treatments in compliance with regulatory standards.
    S02 36C26025Q0047.docx
    The document outlines a Request for Proposals (RFP) by the Department of Veterans Affairs, focused on providing hazardous pharmaceutical compounding services for the Boise Veterans Health Care System. The contract is a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract with a minimum guarantee of $500 and a maximum value of $800,000 over the entire period. Contractors are expected to deliver compounded hazardous chemotherapy agents in compliance with federal and state regulations, specifically USP <797> standards. Orders are to be submitted daily for the next day's treatment, requiring timely delivery by 9:00 am MST. Primary duties include sourcing and aseptically compounding chemotherapy agents per individual patient needs, maintaining stringent quality assurance, and providing contingency plans for service interruptions. The document specifies administrative guidelines, invoicing procedures, and a quality assurance surveillance program to ensure contractor compliance with performance standards. Additionally, it includes various contractual clauses and regulations pertaining to procurement, payment processes, and contractor responsibilities. This acquisition emphasizes the VA’s commitment to ensuring high-quality medical services for veterans while adhering to regulatory requirements and ensuring service reliability.
    Lifecycle
    Title
    Type
    Q517--Pharmacy Compounding Contingency Solicitation for the Boise VA.
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Q517--Staffing Service Tucson
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for staffing services at the Tucson Consolidated Mail Outpatient Pharmacy (CMOP), specifically targeting Service-Disabled Veteran-Owned Small Businesses (SDVOSBs). The contract requires the provision of pharmacists, pharmacy technicians, and shipper/packer personnel to support the processing of over 15 million prescriptions annually, with a minimum contract value of $4 million and a maximum of $250 million over five ordering periods from April 1, 2023, to March 31, 2028. This procurement is critical for maintaining efficient pharmaceutical operations and ensuring compliance with federal regulations, including HIPAA. Interested contractors must submit their proposals by the newly established deadline of July 23, 2024, and can direct inquiries to Contract Specialist Nicholas L. Schulte at nicholas.schulte1@va.gov.
    6505--Mycophenolate Mofetil RFI
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting market research for the procurement of Mycophenolate Mofetil capsules and tablets, intended for use by multiple federal agencies, including the Department of Defense and the Indian Health Service. The objective is to establish a national mandatory requirements contract that will ensure lower pricing based on committed volume, with a preference for a long-term agreement consisting of a base year and up to four option years. This procurement is crucial for maintaining the availability of essential pharmaceuticals within federal healthcare systems. Interested companies must respond by November 19, 2024, providing specific information such as a unique National Drug Code, evidence of manufacturer relationships, and compliance with distribution agreements. For inquiries, contact Amber Zavala at amber.zavala@va.gov or call 708-786-5160.
    Q517--Staffing Service MbM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for staffing services under the Meds by Mail (MbM) program, specifically targeting Service-Disabled Veteran-Owned Small Businesses (SDVOSB). The procurement aims to provide licensed pharmacists and certified pharmacy technicians to support prescription processing across three facilities located in Cheyenne, WY; Dublin, GA; and Murfreesboro, TN. This initiative is crucial for enhancing healthcare services for veterans, ensuring efficient medication management and compliance with established protocols. Interested vendors must submit their proposals by the newly established deadline of August 6, 2024, with a total contract value estimated at $100 million over five years, including a minimum guarantee of $2 million. For further inquiries, potential bidders can contact Nicholas L. Schulte at nicholas.schulte1@va.gov or Christy Pendlay at Christy.Pendlay@va.gov.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0006 to procure Verapamil Hydrochloride (HCL) Tablets. This procurement aims to ensure an uninterrupted supply of the drug for various federal entities, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will have a duration of one year, with the potential for four additional one-year options, and the estimated annual requirements include specific dosages and quantities of the tablets. Interested vendors must submit their proposals by December 4, 2024, and are encouraged to check SAM.gov for updates regarding the solicitation. For inquiries, vendors can contact Contract Specialist Deborah Fassl at Deborah.Fassl@va.gov or by phone at 708-786-5894.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0007 for the procurement of Warfarin Tablets, aimed at ensuring a reliable supply for various federal health agencies, including the Department of Defense and the Bureau of Prisons. This unrestricted procurement will cover multiple tablet strengths and packaging sizes, with an estimated annual usage detailed across 16 product types, and will be awarded for an initial one-year period with options for four additional years. The successful contractor must provide unique labeling and a National Drug Code (NDC) associated with their product, emphasizing the importance of compliance with federal regulations in pharmaceutical supply. Interested vendors should note that the solicitation will be electronically issued around November 13, 2024, with a response deadline of November 27, 2024; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Pegfilgrastim, a critical pharmaceutical product, through its Pharmaceutical Prime Vendor (PPV) program. The objective of this solicitation is to establish a reliable supply chain for specified medications at competitive prices, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and promoting small business participation. Pegfilgrastim is essential for patients undergoing chemotherapy, as it helps to stimulate the production of white blood cells, thereby reducing the risk of infection. Interested offerors must submit proposals that include unique National Drug Codes (NDCs), pricing for a base year and four optional renewal years, and details on compliance with safety standards. For further inquiries, contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the supply of Norethindrone Acetate Tablets under Request for Proposal (RFP) 36E79724R0027. The procurement aims to establish contracts for the pharmaceutical product, with specific requirements regarding pricing for a base year and four option years, compliance with packaging standards, and adherence to the Drug Supply Chain Security Act (DSCSA) regulations. This medication is essential for various health treatments within the VA system, ensuring that veterans receive necessary pharmaceutical care. Interested contractors must submit their proposals by November 15, 2024, at 2:30 PM Central Standard Time, to the designated email addresses provided in the solicitation documents. For further inquiries, potential bidders can contact Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    Q517--After Hours Pharmacy Service – Amarillo TX
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide After Hours Pharmacy Services for the Amarillo VA Medical Center in Texas. The objective is to ensure safe and accurate processing of medication orders through virtual pharmacy services, which will be conducted via a secure web-based system. This initiative is crucial for maintaining high standards in veteran healthcare services, emphasizing the importance of accuracy and safety in medication management. Interested parties must submit a tailored capability statement and relevant business information electronically by November 15, 2024, to the Contracting Officer, Carlos Jaquez, at carlos.jaquez@va.gov, with a subject line indicating their company name and the opportunity title.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Metformin SA Tablets REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL SA Tablets, aimed at ensuring a consistent supply for various governmental entities, including the VA, Department of Defense, Bureau of Prisons, and others. The procurement will cover a one-year contract with the possibility of four additional one-year extensions, requiring offerors to provide a unique National Drug Code (NDC) number and distinct labeling for the supplied products. This initiative is critical for maintaining the availability of essential pharmaceuticals, with estimated annual requirements detailed for two groups: Other Government Agencies and the VA Repack Program. The solicitation, numbered 36E79725R0003, is scheduled for electronic release on December 3, 2024, with a closing date of December 17, 2024. Interested parties can direct inquiries to Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852, and are encouraged to monitor SAM.gov for updates.